These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 30506539)

  • 41. [Clinical analysis of 156 patients with gastrointestinal stromal tumors receiving imatinib therapy].
    Zhang L; Cai M; Deng J; Wang X; Wang B; Liu N; Pan Y; Zhang R; Cui Q; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):331-4. PubMed ID: 24760639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical analysis of efficacy and prognosis of intermediate risk gastric stromal tumor patients].
    Yang HX; Chen HN; Zhang B; Shen CY; Chen ZX; Chen JP
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(16):1230-3. PubMed ID: 23902613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Associations of Preoperative Platelet-to-lymphocyte Ratio and Derived Neutrophil-to-lymphocyte Ratio with thePrognosis of Gastrointestinal Stromal Tumor].
    Yin XN; Tang SM; Yin Y; Shen CY; Zhang B; Chen ZX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):239-243. PubMed ID: 28612534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical management of patients with progressing metastatic gastrointestinal stromal tumors receiving sunitinib treatment: A prospective cohort study.
    Yeh CN; Wang SY; Tsai CY; Chen YY; Liu CT; Chiang KC; Chen TW; Liu YY; Yeh TS
    Int J Surg; 2017 Mar; 39():30-36. PubMed ID: 28110026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Surgical treatment and prognosis of gastrointestinal stromal tumor].
    Lu ZH; Wu XJ; Fang YJ; Pan ZZ; Wan DS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Oct; 14(10):778-80. PubMed ID: 22030776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
    Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
    Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastrointestinal stromal tumors (GIST) related emergencies.
    Sorour MA; Kassem MI; Ghazal Ael-H; El-Riwini MT; Abu Nasr A
    Int J Surg; 2014; 12(4):269-80. PubMed ID: 24530605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.
    Stotz M; Liegl-Atzwanger B; Posch F; Mrsic E; Thalhammer M; Stojakovic T; Bezan A; Pichler M; Gerger A; Szkandera J
    PLoS One; 2016; 11(7):e0159448. PubMed ID: 27454486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Analysis of factors influencing the efficacy and prognosis of surgical treatment for primary malignant pelvic bone tumors].
    Liu WF; Hao L; Li ZY; Jin T; Sun Y; Yang YK; Li Y; Yang FJ; Yu F; Zhang Q; Niu XH
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):344-353. PubMed ID: 38644270
    [No Abstract]   [Full Text] [Related]  

  • 52. Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study.
    Seesing MF; Tielen R; van Hillegersberg R; van Coevorden F; de Jong KP; Nagtegaal ID; Verhoef C; de Wilt JH;
    Eur J Surg Oncol; 2016 Sep; 42(9):1407-13. PubMed ID: 27038995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinicopathological characteristics and prognosis of patients with sporadic multiple primary gastrointestinal stromal tumors].
    Wang T; Zeng XY; Yang WC; Yang M; Fan J; Jia J; Li CG; Liu WZ; Zhang P; Cai KL; Wang GB; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):783-788. PubMed ID: 34530559
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of prognosis for malignant rectal gastrointestinal stromal tumor by clinical parameters and immunohistochemical staining.
    Changchien CR; Wu MC; Tasi WS; Tang R; Chiang JM; Chen JS; Huang SF; Wang JY; Yeh CY
    Dis Colon Rectum; 2004 Nov; 47(11):1922-9. PubMed ID: 15622586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparison of modified NIH and AFIP risk-stratification criteria for gastrointestinal stromal tumors: A multicenter retrospective study].
    Chen T; Qiou H; Feng X; Zhang P; Ye L; Hu Y; Liu H; Yu J; Tao K; Li Y; Zhou Z; Li G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1020-1024. PubMed ID: 28900993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
    Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
    Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Short-term outcomes and prognosis of palliative surgery for malignant bowel obstruction caused by peritoneal metastasis of colorectal cancer].
    Chen PJ; Wang L; Chen N; Lu XY; Wang HS; He X; Wang Z; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1051-1057. PubMed ID: 31770836
    [No Abstract]   [Full Text] [Related]  

  • 59. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
    Joensuu H; Eriksson M; Sundby Hall K; Hartmann JT; Pink D; Schütte J; Ramadori G; Hohenberger P; Duyster J; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Sarlomo-Rikala M; Nilsson B; Sihto H; Monge OR; Bono P; Kallio R; Vehtari A; Leinonen M; Alvegård T; Reichardt P
    JAMA; 2012 Mar; 307(12):1265-72. PubMed ID: 22453568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.